A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Evaluation of Human Epidermal Growth Factor as a Tumor Marker in Patients with Hepatocellular Carcinoma Related to Hepatitis C Virus
2016
Advanced Research in Gastroenterology & Hepatology
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. The primary marker for HCC is Alpha fetoprotein (AFP), however, AFP is not secreted in all cases of HCC and may be normal in as many as 40% of patients with early HCC. Therefore, it was necessary to identify new HCC markers that have a sufficient sensitivity and specificity for the diagnosis of HCC patients. Epidermal growth factor (EGF) is a mitogen for hepatocytes,
doi:10.19080/argh.2016.01.555565
fatcat:koqsypzjzvg3fagd62v3s5wyvm